https://www.selleckchem.com/pr....oducts/PHA-739358(Da
Age was related to migraine duration. The model represents an innovative framework for clinical trial modeling and simulation, and successfully describes placebo effect in migraine prevention. This approach can be adapted to investigate exposure-response relationship of drugs and can also be implemented in other therapeutic areas where the rate, duration and severity of disease episodes are relevant to trial outcomes. The model represents an innovative framework for clinical trial modeling and simulation, and successfully